PRECLINICAL TOXICOLOGY OF ANTICANCER AGENTS.SCHEIN PS.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 6; PP. 1934-1937; BIBL. 11 REF.Article

CHEMOTHERAPEUTIC MANAGEMENT OF THE HORMONE-SECRETING ENDOCRINE MALIGNANCIES = TRAITEMENT CHIMIOTHERAPIQUE DES TUMEURS ENDOCRINIENNES HORMONO-SECRETANTESSCHEIN PS.1972; CANCER.; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1616-1626; BIBL. 2P.Serial Issue

ADJUVANT THERAPY OF GASTRO-INTESTINAL CANCERSCHEIN PS; COOMBES RC.1982; DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH; ISSN 0378-6501; CHE; DA. 1982; VOL. 8; NO 4; PP. 427-433; BIBL. 30 REF.Article

PROGRES THERAPEUTIQUES EN CANCEROLOGIE DIGESTIVE. VII: TRAITEMENT DES CANCERS DU PANCREASSMITH FP; SCHEIN PS.1980; MED. CHIR. DIGEST.; FRA; DA. 1980; VOL. 9; NO 4; PP. 341-347; ABS. ENG/SPA/GER; BIBL. 29 REF.Article

IMMUNOSUPPRESSIVE AND CYTOTOXIC CHEMOTHERAPY: LONG-TERM COMPLICATIONSSCHEIN PS; WINOKUR SH.1975; ANN. INTERN. MED.; U.S.A.; DA. 1975; VOL. 82; NO 1; PP. 84-95; BIBL. 2P.1/2Article

MANAGEMENT OF GASTROINTESTINAL CANCER.HEAL JM; SCHEIN PS.1977; MED. CLIN. N. AMER.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 991-999; BIBL. 2 P. 1/2Article

ENDOCRINE TUMORSCANTRELL J; SCHEIN PS.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 293-297; BIBL. 23 REF.Article

THE MALIGNANT LYMPHOMAS: CURRENT CONCEPTS OF DIAGNOSIS AND MANAGEMENTKILLEN JY; SCHEIN PS.1980; J. DERMATOL. SURG. ONCOL.; USA; DA. 1980; VOL. 6; NO 5; PP. 378-382Article

CHEMOTHERAPY OF PANCREATIC CANCERSMITH FP; SCHEIN PS.1979; SEMINARS IN ONCOL.; USA; DA. 1979; VOL. 6; NO 3; PP. 368-377; BIBL. 54 REF.Article

CLINICAL STUDIES. IV. CLINICAL PHARMACOLOGY AND PHASE I TRIAL DESIGNWOOLLEY PV; SCHEIN PS.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 17; PP. 177-198; BIBL. 2 P.Article

RECENT RESULTS OF CLINICAL THERAPEUTIC TRIALS FOR GASTROINTESTINAL MALIGNANCIES CONDUCTED IN THE UNITED STATESKISNER DL; SCHEIN PS; MACDONALD JS et al.1981; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1981; VOL. 79; PP. 28-40; BIBL. 41 REF.Conference Paper

STRUCTURE-ACTIVITY STUDIES OF METHYLNITROSOUREA ANTITUMOR AGENTS WITH REDUCED MURINE BONE MARROW TOXICITY.PANASCI LC; FOX PA; SCHEIN PS et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 9; PP. 3321-3328; BIBL. 31 REF.Article

HEPATOTOXICITY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU) IN DOGS: THE USE OF SERIAL PERCUTANEOUS LIVER BIOPSIESHENRY MC; DAVIS RD; SCHEIN PS et al.1973; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1973; VOL. 25; NO 3; PP. 410-417; BIBL. 11REF.Article

STREPTOZOTOCIN DIABETES. CORRELATION WITH EXTENT OF DEPRESSION OF PANCREATIC ISLET NICOTINAMIDE ADENINE DINUCLEOTIDE = DIABETE PAR STREPTOZOTOCINE. RELATION AVEC L'EXTENSION DE LA DEPRESSION DE LA NICOTINAMIDE ADENINE DINUCLEOTIDE DES ILOTS PANCREATIQUESANDERSON T; SCHEIN PS; MCMENAMIN MG et al.1974; J. CLIN. INVEST.; U.S.A.; DA. 1974; VOL. 54; NO 3; PP. 672-677; BIBL. 30REF.Article

DOXORUBICIN-INDUCED CHRONIC CARDIOTOXICITY AND ITS PROTECTION BY LIPOSOMAL ADMINISTRATIONAQUILUR RAHMAN; MORE N; SCHEIN PS et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 5; PP. 1817-1825; BIBL. 26 REF.Article

CHEMOTHERAPY OF MALIGNANCIES OF THE GASTROINTESTINAL TRACT.WOOLEY PV III; MACDONALD JS; SCHEIN PS et al.1977; PROGR. IN GASTROENTEROL.; U.S.A.; DA. 1977; VOL. 3; PP. 671-692; BIBL. 4 P.Article

BIOLOGY, DIAGNOSIS, AND CHEMOTHERAPEUTIC MANAGEMENT OF PANCREATIC MALIGNANCY.MACDONALD JS; WIDERLITE L; SCHEIN PS et al.1977; ADV. PHARMACOL. CHEMOTHERAPY; U.S.A.; DA. 1977; VOL. 14; PP. 107-142; BIBL. 5 P. 1/2Article

STRUCTURES OF THE DECOMPOSITION PRODUCTS OF CHLOROZOTOCIN: NEW INTRAMOLECULAR CARBAMATES OF 2-AMINO-2-DEOXYHEXOSESHAMMER CF; LORANGER RA; SCHEIN PS et al.1981; J. ORG. CHEM.; ISSN 0022-3263; USA; DA. 1981; VOL. 46; NO 8; PP. 1521-1531; BIBL. 60 REF.Article

PRECLINICAL AND CLINICAL STUDIES ON CHLOROZOTOCIN, A NEW NITROSOUREA WITH DECREASED BONE MARROW TOXICITYMACDONALD JS; HOTH D; SCHEIN PS et al.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 83-89; BIBL. 12 REF.Conference Paper

CHLOROZOTOCIN. MECHANISM OF REDUCED BONE MARROW TOXICITY IN MICEPANASCI LC; GREEN D; SCHEIN PS et al.1979; J. CLIN. INVEST.; USA; DA. 1979; VOL. 64; NO 4; PP. 1103-1111; BIBL. 31 REF.Article

A STRUCTURE-ACTIVITY STUDY OF SEVEN NEW WATER SOLUBLE NITROSOUREASHEAL JM; FOX P; SCHEIN PS et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 8; PP. 1301-1306; BIBL. 26 REF.Article

A COMPARISON OF THE BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF 1-(4-AMINO-2-METHYLPYRIMIDIN-5-YL) METHYL-3-(2-CHLOROETHYL)-3-NITROSOUREA AND 2-(3-(2-CHLOROETHYL-3-NITROSOUREIDO)-D-GLUCOPYRANOSE.NAGOURNEY RA; FOX P; SCHEIN PS et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 1; PP. 65-68; BIBL. 15 REF.Article

SPONTANEOUS STREPTOCOCCUS PNEUMONIA PERITONITIS IN A PATIENT WITH METASTATIC GASTRIC CANCER. A CASE REPORT AND ETIOLOGIC CONSIDERATION.ISNER J; MACDONALD JS; SCHEIN PS et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 5; PP. 2306-2309; BIBL. 13 REF.Article

BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF 1-(2-CHLOROETHYL)-3-(BETA -D-GLUCOPYRANOSYL)-1-NITROSOUREA (NSC-D 254157), A NITROSOUREA WITH REDUCED BONE MARROW TOXICITY.FOX PA; PANASCI LC; SCHEIN PS et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 3; PP. 783-787; BIBL. 14 REF.Article

ENHANCED ANTITUMOR EFFECT OF CYTOSINE ARABINOSIDE GIVEN IN A SEHEDULE DICTATED BY KINETIC STUDIES IN VIVO = ACCROISSEMENT DE L'EFFET ANTITUMORAL DU CYTOSINE-ARABINOSIDE DANS UN PROGRAMME COMMANDE PAR DE RECHERCHES CINETIQUES IN VIVOYOUNG RC; GOLDBERG D; SCHEIN PS et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 2; PP. 277-280; BIBL. 8 REF.Serial Issue